Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.9%

14 terminated/withdrawn out of 747 trials

Success Rate

91.0%

+4.5% vs industry average

Late-Stage Pipeline

11%

82 trials in Phase 3/4

Results Transparency

5 of 142 completed trials have results

Key Signals

121 recruiting5 with results10 withdrawn

Enrollment Performance

Analytics

N/A

209(42.7%)

Phase 2

146(29.9%)

Phase 4

47(9.6%)

Phase 1

45(9.2%)

Phase 3

35(7.2%)

Early Phase 1

7(1.4%)

489Total

N/A(209)

Phase 2(146)

Phase 4(47)

Phase 1(45)

+2 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (747)

Showing 20 of 747 trials

NCT06748690Not ApplicableRecruiting

MCB vs EUS-FNA for Preoperative Pathological Evaluation of Gastric SMT

Role: lead

NCT07533825Not ApplicableEnrolling By Invitation

Laparoscopic Staging for Stage III Gastric Cancer

Role: collaborator

NCT07532122Completed

Postoperative Anxiety and Depression Among Chinese Elderly Patients

Role: collaborator

NCT07523139Recruiting

Vitreous Zonule in Primary Angle-Closure Glaucoma

Role: lead

NCT07511595Not Yet Recruiting

Blood mNGS for Diagnosing Invasive Pulmonary Fungal Disease in Hematologic Patients

Role: lead

NCT07517484Not ApplicableRecruiting

Light and Anesthesia

Role: lead

NCT07517302Not ApplicableRecruiting

Kahook Dual Blade Goniotomy in Chronic Primary Angle-Closure Glaucoma

Role: lead

NCT07487883Recruiting

Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors

Role: lead

NCT07498933Recruiting

FAP-targeted PET/NIR in Lung Malignant Tumors

Role: lead

NCT07500441Recruiting

Digital PCR of CHIP and MR for MRD Monitoring After Allo-HSCT in AML

Role: lead

NCT06886048Not ApplicableRecruiting

Effects of Barley Green on Visceral Fat Area in the Human Body and Investigation Into the Associated Mechanism of Intestinal Microbiota

Role: lead

NCT07400263Not ApplicableRecruiting

Evaluation of an EpCAM-Targeted Radiotracer in Epithelial Tumors

Role: lead

NCT06880913Phase 1Recruiting

Nanobody-Based CD19/CD22 Tandem Dual CAR-T Therapy for R/R B-ALL

Role: lead

NCT07494006Enrolling By Invitation

Spontaneous Breathing Mode: A Risk for Hypoxemia During OLV?

Role: lead

NCT06269393Phase 3Completed

A Study of IBI311 in Subjects With Steroid-resistant, Thyroid Associated Ophthalmopathy

Role: lead

NCT07101588Phase 4Recruiting

Ruxolitinib-Decitabine Intensified Conditioning Regimen for AML: A Randomized Trial

Role: collaborator

NCT07474571Recruiting

Evaluation of Musculoskeletal Aging and Related Disorders Via Advanced Clinical Imaging

Role: lead

NCT07484087Not ApplicableRecruiting

Ablation Compare With Surgery for Early Breast Cancer

Role: lead

NCT07294339Not ApplicableNot Yet Recruiting

A Randomized Controlled Trial of Acupuncture for the Management of Hot Flashes in Patients With Hormone Receptor-Positive Breast Cancer

Role: lead

NCT07479732Phase 1Recruiting

Apatinib Combined With Liposomal Irinotecan for Refractory or Metastatic Osteosarcoma

Role: lead